Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era.
Sean A FletcherMufaddal M MamawalaAlbert E HollerYasin BhanjiKatarzyna J MacuraClaire M de la CalleChristian P PavlovichPublished in: The Prostate (2024)
The CCLO score is a valid, objective metric to predict GR and receipt of treatment in a large AS cohort. The ability of the MRI-informed mCCLO to predict GR is on par with traditional metrics of tumor volume but is more descriptive and may benefit from greater reproducibility. The mCCLO score can be implemented as a shorthand, informative tool for counseling patients about whether to remain on AS.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- prostate cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- diffusion weighted imaging
- cross sectional
- magnetic resonance
- smoking cessation
- computed tomography
- adipose tissue
- squamous cell carcinoma
- young adults
- hepatitis c virus
- skeletal muscle
- men who have sex with men
- hiv testing
- patient reported
- glycemic control